Bio Detection

Bio Detection Market Outlook

The global bio-detection market is projected to reach approximately USD 25 billion by the year 2035, with a compound annual growth rate (CAGR) of around 8.5% during the forecast period from 2025 to 2035. The growth factor for this market is primarily driven by the increasing demand for rapid and accurate diagnostic solutions in the healthcare sector, which has been significantly influenced by the rising prevalence of infectious diseases and genetic disorders globally. Moreover, advancements in molecular biology techniques and the growing emphasis on food safety and environmental monitoring are further propelling the demand for bio-detection technologies. Additionally, ongoing research and development activities aimed at improving bio-detection methods are expected to enhance market growth, making it a focal point for investments and innovations in the coming years.

Growth Factor of the Market

The bio-detection market is experiencing robust growth due to several key factors. Firstly, the increasing incidence of chronic and infectious diseases has escalated the need for effective and timely diagnosis, positioning bio-detection technologies as critical tools in medical settings. Secondly, the rise of personalized medicine has necessitated the development of advanced diagnostic tools that can provide specific and accurate results, thus creating a favorable environment for bio-detection solutions. Additionally, the growing awareness of food safety among consumers, coupled with stricter regulatory requirements, has led industries to invest in bio-detection solutions to ensure compliance and safeguard public health. The technological advancements in biosensors and molecular biology, which enhance the sensitivity and specificity of detection methods, are also contributing significantly to market expansion. Lastly, the increasing government funding and support for research initiatives in biotechnology and diagnostics are expected to further stimulate market growth.

Key Highlights of the Market

• The bio-detection market is forecasted to reach USD 25 billion by 2035.
• CAGR of 8.5% projected from 2025 to 2035.
• Healthcare sector drives the majority market share due to rising disease prevalence.
• Technological advancements enhance the accuracy and speed of bio-detection methods.
• Increased regulatory scrutiny on food safety promotes adoption of bio-detection technologies.

By Product Type

Biometric Sensors:

Biometric sensors play a vital role in the bio-detection market by enabling the identification and verification of individuals based on biological characteristics such as fingerprints, facial recognition, and iris patterns. These sensors are increasingly being integrated into security systems in various settings, including healthcare facilities, to prevent unauthorized access to sensitive patient data and medical equipment. Their application extends beyond security, as they are also employed in patient monitoring systems to track health metrics and provide timely alerts. The adoption of biometric sensors is expected to grow as organizations focus on enhancing security protocols and improving patient care management systems, thus driving the overall demand in the bio-detection market.

DNA Probes:

DNA probes are essential tools in the field of molecular diagnostics, allowing for the detection of specific genetic sequences associated with diseases. These probes facilitate the identification of pathogens in clinical samples, which is crucial for accurate diagnosis and treatment planning. The market for DNA probes is expanding significantly due to the increasing prevalence of genetic disorders and infectious diseases, along with the rising interest in genetic research and personalized medicine. Furthermore, advancements in probe design and hybridization techniques have improved the sensitivity and specificity of these products, making them indispensable in both clinical and research laboratories.

Immunoassays:

Immunoassays are widely used bio-detection techniques that leverage the specificity of antibodies to detect various biological substances, including hormones, proteins, and pathogens. This product type has gained significant traction in clinical diagnostics, particularly in the detection of infectious diseases and monitoring of therapeutic drug levels. The versatility of immunoassays allows them to be adapted for various applications, including point-of-care testing, which further enhances their market appeal. The continuous development of novel assays and reagents is expected to drive growth in this segment, supported by an increasing emphasis on early disease detection and management.

Biosensors:

Biosensors are analytical devices that combine a biological component with a physicochemical detector to observe biological events. This product type is crucial for real-time monitoring of various parameters, including glucose levels in diabetic patients. The biosensor market is expanding rapidly due to the growing demand for portable and rapid testing solutions across multiple sectors, including healthcare, environmental monitoring, and food safety. Innovations in nanotechnology and electrochemical sensors are further driving advancements in biosensor technology, making them more reliable, sensitive, and user-friendly, thus fostering broader adoption in the bio-detection market.

Microarrays:

Microarrays are powerful tools that allow researchers to analyze multiple biological samples simultaneously, providing insights into gene expression and genetic variations. This product type is particularly valuable in genomics and molecular diagnostics, where it aids in the identification of disease biomarkers and the development of targeted therapies. As the field of precision medicine continues to grow, the demand for microarrays is expected to increase, driven by their ability to provide comprehensive data in a high-throughput format. The integration of microarrays with advanced data analysis techniques is further enhancing their utility in both clinical and research contexts.

By Application

Medical Diagnosis:

The medical diagnosis segment is one of the largest applications of bio-detection technologies, encompassing various diagnostic tests that enable healthcare professionals to identify diseases accurately and promptly. The rising prevalence of infectious diseases, coupled with an increasing aging population, has fueled the demand for advanced diagnostics that can provide rapid and reliable results. Furthermore, the COVID-19 pandemic has highlighted the importance of bio-detection in public health, driving investments in diagnostic capabilities. Continuous technological advancements are enhancing diagnostic accuracy and efficiency, ultimately improving patient outcomes and supporting the overall growth of the bio-detection market.

Environmental Monitoring:

Environmental monitoring is another critical application of bio-detection technologies, which involves the assessment of environmental pollutants and pathogens to ensure public health and safety. This segment has gained prominence as awareness of environmental issues such as climate change and pollution has increased significantly. Bio-detection methods enable the detection of harmful microorganisms, toxins, and chemicals in air, water, and soil, making them essential for regulatory compliance and environmental protection. The growing emphasis on sustainability and environmental conservation is expected to drive further adoption of bio-detection technologies in this application area.

Food Safety:

Food safety is an increasingly important application of bio-detection technologies, as consumers are becoming more concerned about the safety and quality of the food they consume. Bio-detection methods allow for the rapid identification of foodborne pathogens, contaminants, and allergens, helping to prevent foodborne illnesses and ensure compliance with food safety regulations. The food industry is investing in bio-detection solutions to enhance quality control processes and protect public health. As food safety standards become more stringent globally, the demand for bio-detection technologies in this sector is expected to rise significantly, driving market growth.

Biodefense:

Biodefense involves the protection against biological threats, including bioterrorism and pandemics, making it a crucial application of bio-detection technologies. The rising concern over biological warfare and the potential for emerging infectious diseases has led to increased investments in biodefense initiatives. Bio-detection technologies play a vital role in early detection and response to biological threats, enabling rapid identification and containment measures to protect public health. As governments and organizations prioritize biodefense strategies, the demand for advanced bio-detection solutions is expected to grow, contributing to the overall expansion of the market.

Veterinary Diagnostics:

Veterinary diagnostics is a key application area for bio-detection technologies, focusing on the diagnosis of diseases in animals. The growing awareness of zoonotic diseases, which can be transmitted from animals to humans, has heightened the need for effective diagnostic solutions in veterinary medicine. Bio-detection methods enable the rapid identification of pathogens in animal populations, ensuring timely treatment and management of diseases. With the increasing pet ownership and livestock farming, the demand for veterinary diagnostics is expected to rise significantly, driving growth in the bio-detection market.

By Technology

PCR:

Polymerase Chain Reaction (PCR) is a widely used technology in bio-detection that enables the amplification of specific DNA sequences, facilitating the detection of pathogens and genetic disorders. PCR has revolutionized molecular diagnostics due to its high sensitivity and specificity, making it a cornerstone in clinical laboratories. The increasing demand for rapid and accurate testing solutions, particularly in infectious disease diagnostics, has driven the adoption of PCR technology. Moreover, advancements in real-time PCR and multiplex PCR techniques are enhancing the capabilities of this technology, allowing for simultaneous detection of multiple targets, thus contributing to market growth.

ELISA:

Enzyme-Linked Immunosorbent Assay (ELISA) is another widely employed bio-detection technology used for quantifying proteins, hormones, and antibodies in various samples. ELISA is favored for its simplicity, cost-effectiveness, and versatility, making it a preferred choice in clinical laboratories for disease diagnosis and monitoring. The growing need for accurate immunodiagnostics, especially in infectious disease detection and monitoring, is fueling the demand for ELISA-based assays. Furthermore, innovations in ELISA formats and the integration of automation are expected to enhance the efficiency and throughput of this technology, driving further adoption in the bio-detection market.

Microfluidics:

Microfluidics technology involves the manipulation of small volumes of fluids within micro-scale channels, enabling highly sensitive and efficient bio-detection applications. This technology is gaining traction in various fields, including diagnostics, drug discovery, and environmental monitoring, due to its ability to perform multiple analyses simultaneously on a small scale. The miniaturization of diagnostic assays through microfluidics enhances the speed and accuracy of results, making it an attractive option for point-of-care testing. As the demand for portable and rapid testing solutions continues to rise, microfluidics technology is expected to play a significant role in the growth of the bio-detection market.

Next Generation Sequencing:

Next Generation Sequencing (NGS) represents a breakthrough in bio-detection technologies, allowing for the rapid sequencing of entire genomes and the identification of genetic variations. NGS has transformed fields such as genomics, oncology, and infectious disease research by providing comprehensive data on genetic profiles. The increasing prevalence of genetic disorders and the demand for personalized medicine are driving the adoption of NGS technologies in clinical diagnostics. As researchers and clinicians seek to leverage genomic data for improved patient outcomes, the NGS segment is poised for substantial growth within the bio-detection market.

Mass Spectrometry:

Mass Spectrometry (MS) is a sophisticated analytical technique used in bio-detection for the identification and quantification of biomolecules based on their mass-to-charge ratio. This technology is widely utilized in proteomics, metabolomics, and environmental analysis, providing highly accurate and detailed information about biological samples. The demand for mass spectrometry is increasing due to its ability to analyze complex mixtures and provide insights into biological processes. As advancements in mass spectrometry instrumentation and data analysis continue to evolve, the technology is expected to see significant growth within the bio-detection market, particularly in research and clinical applications.

By User

Hospitals & Clinics:

Hospitals and clinics are the primary users of bio-detection technologies, leveraging these solutions for accurate diagnostics and patient management. The increasing patient population and the rising demand for effective disease detection are driving the adoption of advanced bio-detection tools in healthcare settings. Furthermore, the emphasis on early diagnosis and personalized treatment plans is prompting hospitals and clinics to invest in innovative bio-detection technologies. With the integration of diagnostic tools in electronic health records and the growing trend of point-of-care testing, the use of bio-detection technologies in hospitals and clinics is anticipated to continue expanding.

Research Laboratories:

Research laboratories are significant users of bio-detection technologies, utilizing these solutions for various applications, including drug discovery, genetic research, and infectious disease studies. The continuous need for advanced research methodologies is driving the demand for innovative bio-detection tools that can enhance experimental accuracy and efficiency. Additionally, the growing focus on personalized medicine and targeted therapies is further propelling investments in bio-detection technologies within research laboratories. As researchers seek to uncover new insights into biological processes, the bio-detection market is expected to witness substantial growth in this user segment.

Food Industry:

The food industry is increasingly adopting bio-detection technologies to ensure food safety and quality, driven by consumer demand and regulatory requirements. These technologies enable rapid detection of foodborne pathogens, contaminants, and allergens, helping food manufacturers comply with safety standards and protect public health. As the food industry continues to prioritize quality control and risk management, the demand for bio-detection solutions is expected to rise significantly. Furthermore, ongoing advancements in bio-detection methods are enhancing their sensitivity and efficiency, further solidifying their importance in the food industry.

Pharmaceutical Industry:

The pharmaceutical industry is a crucial user of bio-detection technologies, leveraging these solutions for drug development, quality control, and clinical trials. The increasing complexity of drug formulations and the growing emphasis on regulatory compliance are driving the need for accurate and efficient bio-detection tools in this sector. Additionally, the rising focus on personalized medicine and targeted therapies is prompting pharmaceutical companies to invest in innovative bio-detection technologies that can support their research and development efforts. As the pharmaceutical landscape continues to evolve, the demand for bio-detection solutions is expected to grow significantly within this user segment.

Environmental Agencies:

Environmental agencies are significant users of bio-detection technologies, utilizing these solutions for monitoring environmental pollutants and ensuring public health safety. The increasing awareness of environmental issues, such as climate change and pollution, is driving the demand for effective bio-detection tools that can accurately assess environmental quality. Bio-detection technologies enable environmental agencies to detect harmful substances in air, water, and soil, facilitating timely interventions and compliance with regulatory standards. As environmental concerns continue to escalate, the role of bio-detection technologies in supporting environmental agencies is expected to grow, contributing to the overall expansion of the market.

By Region

The North American region holds the largest share of the global bio-detection market, accounting for approximately 40% of the total market revenue in 2023. This dominance is primarily attributed to the high adoption of advanced healthcare technologies, robust research infrastructure, and significant investments in biotechnology and pharmaceuticals. The increasing focus on personalized medicine and rising prevalence of infectious diseases in the region are further driving the demand for bio-detection solutions. The CAGR for this region is projected to be around 9% during the forecast period, reflecting strong growth potential as healthcare organizations continue to enhance their diagnostic capabilities.

Europe is the second-largest market for bio-detection, contributing around 30% to the global revenue. The increasing awareness of food safety, stringent regulatory frameworks, and a growing emphasis on environmental monitoring are driving the demand for bio-detection technologies in this region. Additionally, the presence of established pharmaceutical companies and research institutions further supports the growth of the bio-detection market in Europe. The region is expected to witness a CAGR of approximately 7% during the forecast period, driven by ongoing advancements in technology and increasing investments in healthcare and environmental initiatives.

Opportunities

The bio-detection market presents numerous opportunities for growth, particularly in the realm of personalized medicine. As the healthcare industry increasingly shifts towards tailored treatments based on individual patient profiles, bio-detection technologies will play a pivotal role in identifying biomarkers and genetic variations that guide therapy decisions. Companies focusing on developing innovative diagnostic tools that cater to the personalized medicine market are likely to gain a competitive edge. Furthermore, the integration of artificial intelligence (AI) and machine learning algorithms into bio-detection technologies can enhance data analysis, improve diagnostic accuracy, and enable the development of predictive models, paving the way for new business avenues and partnerships.

Another promising opportunity lies in emerging markets, where the demand for advanced healthcare solutions is on the rise. Countries in Asia-Pacific, Latin America, and the Middle East & Africa are witnessing increased investments in healthcare infrastructure and diagnostic capabilities. As these regions continue to develop, there will be a growing need for bio-detection technologies to address public health challenges, such as infectious disease outbreaks and food safety concerns. Companies looking to expand their presence in these markets can leverage strategic partnerships and local collaborations to tap into the burgeoning demand for bio-detection solutions, ultimately driving their growth in the global landscape.

Threats

Despite its growth potential, the bio-detection market faces several threats that could impact its progress. One significant threat is the rapid pace of technological advancements, which can lead to market saturation and intense competition among existing players. As new companies enter the market with innovative solutions, established firms may struggle to maintain their market share, particularly if they fail to adapt to changing consumer demands and technological trends. Additionally, the continuous evolution of pathogens and emerging infectious diseases poses a challenge for bio-detection technologies, as diagnostic methods may need to be updated frequently to remain effective. This dynamic landscape requires companies to invest constantly in research and development to stay ahead, potentially straining their resources.

Another threat to the bio-detection market is regulatory challenges, as stringent regulations govern the approval and use of diagnostic technologies. Companies must navigate complex regulatory environments to bring their products to market, which can result in delayed product launches and increased costs. Furthermore, changes in regulatory requirements can create uncertainty in the market, making it difficult for companies to plan their strategies effectively. The ever-evolving landscape of regulations requires firms to remain vigilant and adaptable, ensuring compliance while also pursuing innovation to meet market demands.

Competitor Outlook

• Thermo Fisher Scientific
• Abbott Laboratories
• Roche Diagnostics
• Siemens Healthineers
• Danaher Corporation
• BD (Becton, Dickinson and Company)
• Agilent Technologies
• Bio-Rad Laboratories
• PerkinElmer, Inc.
• Hologic, Inc.
• Qiagen N.V.
• Merck KGaA
• Illumina, Inc.
• Genomatix Software GmbH
• Sysmex Corporation

The competitive landscape of the bio-detection market is characterized by the presence of several key players striving to maintain their market position through innovation and strategic collaborations. Companies are increasingly investing in research and development to enhance their product offerings, improve diagnostic accuracy, and reduce time-to-result. Moreover, partnerships between academic institutions and private companies are fostering innovation and enabling the development of cutting-edge bio-detection technologies. As the market continues to grow, firms with strong research capabilities and a focus on customer needs will likely emerge as leaders in the industry.

Among the key players, Thermo Fisher Scientific stands out as a market leader, offering a diverse portfolio of bio-detection solutions, including molecular diagnostics, immunoassays, and biosensors. The company's focus on innovation and strategic acquisitions has positioned it well in the bio-detection market. Similarly, Abbott Laboratories is recognized for its advanced diagnostic technologies, including point-of-care testing solutions that cater to the growing demand for rapid diagnostics. With a commitment to improving patient outcomes, Abbott is continuously expanding its product offerings to meet the evolving needs of healthcare providers.

Roche Diagnostics is another major player in the bio-detection market, known for its comprehensive range of diagnostic tests and solutions. The company has a strong emphasis on personalized medicine and is actively involved in the development of novel bio-detection technologies. Additionally, Siemens Healthineers is leveraging advancements in imaging and laboratory diagnostics to enhance its bio-detection capabilities, aimed at providing integrated healthcare solutions. These companies, along with several others, are shaping the future of the bio-detection market by driving innovation and addressing the growing demand for effective diagnostic solutions.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Merck KGaA
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Qiagen N.V.
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Hologic, Inc.
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Illumina, Inc.
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 PerkinElmer, Inc.
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Roche Diagnostics
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Sysmex Corporation
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Abbott Laboratories
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Danaher Corporation
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Agilent Technologies
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Bio-Rad Laboratories
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Siemens Healthineers
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Genomatix Software GmbH
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Thermo Fisher Scientific
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 BD (Becton, Dickinson and Company)
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Bio Detection Market, By User
    • 6.1.1 Hospitals & Clinics
    • 6.1.2 Research Laboratories
    • 6.1.3 Food Industry
    • 6.1.4 Pharmaceutical Industry
    • 6.1.5 Environmental Agencies
  • 6.2 Bio Detection Market, By Application
    • 6.2.1 Medical Diagnosis
    • 6.2.2 Environmental Monitoring
    • 6.2.3 Food Safety
    • 6.2.4 Biodefense
    • 6.2.5 Veterinary Diagnostics
  • 6.3 Bio Detection Market, By Product Type
    • 6.3.1 Biometric Sensors
    • 6.3.2 DNA Probes
    • 6.3.3 Immunoassays
    • 6.3.4 Biosensors
    • 6.3.5 Microarrays

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Bio Detection Market by Region
  • 10.4 Latin America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 Brazil
      • 10.4.1.2 Argentina
      • 10.4.1.3 Mexico
  • 10.5 North America - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 USA
      • 10.5.1.2 Canada
  • 10.6 Middle East & Africa - Market Analysis
    • 10.6.1 By Country
      • 10.6.1.1 Middle East
      • 10.6.1.2 Africa

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Bio Detection market is categorized based on

By Product Type

• Biometric Sensors
• DNA Probes
• Immunoassays
• Biosensors
• Microarrays

By Application

• Medical Diagnosis
• Environmental Monitoring
• Food Safety
• Biodefense
• Veterinary Diagnostics

By User

• Hospitals & Clinics
• Research Laboratories
• Food Industry
• Pharmaceutical Industry
• Environmental Agencies

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Thermo Fisher Scientific
• Abbott Laboratories
• Roche Diagnostics
• Siemens Healthineers
• Danaher Corporation
• BD (Becton, Dickinson and Company)
• Agilent Technologies
• Bio-Rad Laboratories
• PerkinElmer, Inc.
• Hologic, Inc.
• Qiagen N.V.
• Merck KGaA
• Illumina, Inc.
• Genomatix Software GmbH
• Sysmex Corporation